199 related articles for article (PubMed ID: 29453032)
1. Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Epidemiol; 2018 Apr; 53():149-155. PubMed ID: 29453032
[TBL] [Abstract][Full Text] [Related]
2. Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
Zheng J; Santoni G; Xie SH; Lagergren J
Br J Cancer; 2021 Jul; 125(2):277-283. PubMed ID: 33972744
[TBL] [Abstract][Full Text] [Related]
3. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
[TBL] [Abstract][Full Text] [Related]
4. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
5. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Causes Control; 2019 Apr; 30(4):385-393. PubMed ID: 30820714
[TBL] [Abstract][Full Text] [Related]
6. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
10. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies.
Bahardoust M; Mousavi S; Moezi ZD; Yarali M; Tayebi A; Olamaeian F; Tizmaghz A
J Gastrointest Cancer; 2024 Mar; 55(1):65-76. PubMed ID: 37526857
[TBL] [Abstract][Full Text] [Related]
11. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
[TBL] [Abstract][Full Text] [Related]
12. Statin use and survival in patients with gastric cancer in two independent population-based cohorts.
Spence AD; Busby J; Hughes CM; Johnston BT; Coleman HG; Cardwell CR
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):460-470. PubMed ID: 30456916
[TBL] [Abstract][Full Text] [Related]
13. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
[TBL] [Abstract][Full Text] [Related]
14. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
16. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
Baglia ML; Cui Y; Zheng T; Yang G; Li H; You M; Xu L; Murff H; Gao YT; Zheng W; Xiang YB; Shu XO
Cancer Res Treat; 2019 Apr; 51(2):538-546. PubMed ID: 29986576
[TBL] [Abstract][Full Text] [Related]
17. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
18. Population-based cohort study of diabetes mellitus and mortality in gastric adenocarcinoma.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Surg; 2018 Dec; 105(13):1799-1806. PubMed ID: 30051463
[TBL] [Abstract][Full Text] [Related]
19. Metformin use and survival from lung cancer: A population-based cohort study.
Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
[TBL] [Abstract][Full Text] [Related]
20. Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
Liu P; McMenamin ÚC; Spence AD; Johnston BT; Coleman HG; Cardwell CR
BMC Cancer; 2019 Oct; 19(1):1017. PubMed ID: 31664951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
